Stay updated with breaking news from Oxular Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
24 Oct 2023 Initial safety, efficacy and durability data expected in 2H'24 OXFORD, UK and CAMBRIDGE, Mass. - October 24, 2023 -Oxular Limited, a...
OXFORD, United Kingdom & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oxular Limited, a clinical-stage ophthalmic company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announces that Mark Gaffney has been appointed as chief executive officer (CEO) and member of the Board...
Appointment builds Oxular’s team as it prepares to enter human clinical studies evaluating OXU-001 OXFORD, UK, 8 February 2021 – Oxular Limited (“Oxular”), a leading retinal therapeutics development company, today announces that it has appointed Dr. Jatinder Kapur as Vice President of Quality. His primary responsibilities include establishing and managing the Company’s Quality Management System, while also supporting other functions, as the Company prepares to enter human clinical studies evaluating OXU-001. OXU-001 is the Company’s 12-month treatment for inflammatory retinal dise...